The Foundation supports research across basic, translational and clinical science to speed breakthroughs that can lead to the creation of new treatments and a better quality of life for people with Parkinson's disease.
Search or browse funded studies
Previously funded studies appear chronologically, with the most recent appearing first.
-
Understanding LRRK2 Biology, 2009Building a LRRK2 Cohort Core Database
Objective/Rationale:
MJFF is funding the expansion of two international LRRK2 cohorts to gain insight into the relationship of this genetic mutation to Parkinson’s disease. Within each funded study... -
MJFF Research Grant, 2009A Pre-clinical Alpha-Synuclein Model of Parkinson's Disease
Objective/Rationale:
This project will aim to establish the behavioral and neuroanatomical correlates of injecting a viral vector that overexpresses the gene for alpha-synuclein into the brains of non... -
Clinicopathological Correlations of Parkinson’s Disease, 2009Evaluation of the Enteric Nervous System in PD
Objective/Rationale:
Gastrointestinal (GI) symptoms (constipation, for example) afflict essentially every PD patient, negatively impact quality of life, and diminish effectiveness of oral medications... -
Clinicopathological Correlations of Parkinson’s Disease, 2009Metabolomic Analysis of Parkinson's Disease Cerebrospinal Fluid
Objective/Rationale:
Metabolomic analysis is a state-of-the-art laboratory technique and computerized analysis used to catalog hundreds of the chemical constituents in the brain environment. We will... -
Clinicopathological Correlations of Parkinson’s Disease, 2009Identification of Alpha-synuclein Molecular Forms Correlating with Clinicopathology of Parkinson's Disease
Objective/Rationale:
A systematic characterization of alpha-synuclein from human tissue using high-resolution mass spectrometry has not been reported. A detailed study of alpha synuclein modifications... -
Clinicopathological Correlations of Parkinson’s Disease, 2009miRNAs as new therapeutic targets and diagnostic biomarkers of PD
Objective/Rationale:
microRNAs are newly recognized, small regulatory molecules, playing important roles in normal functions and disease. However, their roles in Parkinson’s disease are still largely...
Apply for a Grant
Our funding programs support basic, translational and clinical research from academia and industry.